Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
3.60
Dollar change
-0.28
Percentage change
-7.22
%
Index- P/E- EPS (ttm)-4.50 Insider Own25.35% Shs Outstand1.09M Perf Week18.03%
Market Cap4.35M Forward P/E- EPS next Y-5.20 Insider Trans0.00% Shs Float0.90M Perf Month23.29%
Income-4.26M PEG- EPS next Q- Inst Own6.10% Short Float3.42% Perf Quarter36.36%
Sales0.48M P/S9.07 EPS this Y-27.44% Inst Trans105.57% Short Ratio0.01 Perf Half Y7.27%
Book/sh1.34 P/B2.69 EPS next Y33.76% ROA-170.50% Short Interest0.03M Perf Year-55.00%
Cash/sh1.12 P/C3.22 EPS next 5Y- ROE-231.67% 52W Range2.21 - 12.00 Perf YTD18.03%
Dividend Est.- P/FCF- EPS past 5Y-190.11% ROI-292.24% 52W High-70.00% Beta0.19
Dividend TTM- Quick Ratio2.97 Sales past 5Y20.14% Gross Margin99.40% 52W Low62.90% ATR (14)0.63
Dividend Ex-Date- Current Ratio2.97 EPS Y/Y TTM24.79% Oper. Margin-901.46% RSI (14)53.30 Volatility15.63% 13.26%
Employees7 Debt/Eq0.05 Sales Y/Y TTM0.78% Profit Margin-881.73% Recom1.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q29.85% Payout- Rel Volume0.12 Prev Close3.88
Sales Surprise0.00% EPS Surprise-3.13% Sales Q/Q-22.75% EarningsNov 27 Avg Volume2.25M Price3.60
SMA2012.61% SMA5017.65% SMA200-4.74% Trades Volume278,450 Change-7.22%
Feb-11-25 10:52AM
05:46AM
Feb-06-25 06:00AM
Jan-10-25 01:24PM
Dec-31-24 11:55AM
02:28PM Loading…
Dec-18-24 02:28PM
Dec-03-24 08:30AM
Nov-21-24 05:30AM
Nov-12-24 05:30AM
Nov-01-24 04:30PM
Oct-29-24 08:30AM
Oct-15-24 05:00AM
Oct-09-24 10:47AM
Sep-25-24 08:30AM
Sep-24-24 08:00AM
08:00AM Loading…
Aug-27-24 08:00AM
Aug-22-24 05:00AM
Aug-21-24 05:00AM
Aug-12-24 06:52AM
05:00AM
Aug-01-24 04:05PM
08:00AM
Jul-29-24 05:00AM
May-31-24 08:00AM
May-29-24 12:53PM
08:00AM
May-24-24 01:53PM
May-21-24 08:00AM
Apr-17-24 08:00AM
Apr-05-24 08:00AM
08:00AM Loading…
Apr-03-24 08:00AM
Mar-07-24 03:23PM
Mar-05-24 08:00AM
Feb-20-24 08:00AM
Dec-20-23 08:00AM
Nov-12-23 08:20PM
Nov-10-23 08:00AM
Oct-25-23 04:05PM
Oct-24-23 08:00AM
Oct-23-23 08:45AM
08:30AM
Oct-20-23 08:00AM
Sep-21-23 08:30AM
Jun-13-23 08:30AM
May-15-23 09:15AM
May-14-23 08:12AM
May-01-23 08:30AM
Apr-17-23 08:30AM
Apr-05-23 08:30AM
Mar-31-23 08:00AM
Mar-16-23 08:30AM
Mar-01-23 08:00AM
Jan-11-23 07:30AM
Jan-09-23 08:00AM
Dec-22-22 04:05PM
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaufman Jonathan HSee remarks below.May 14 '24Buy0.7610,0007,590898,849May 15 04:39 PM
Kaufman Jonathan HSee remarks below.Mar 18 '24Buy0.7930,00023,649863,849Mar 19 06:21 PM
Kaufman Jonathan HSee remarks below.Mar 19 '24Buy0.8725,00021,802888,849Mar 19 06:21 PM